Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fidaxomicin PK in IBD Patients with CDI
NCT02437591Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Aug 2015
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 4 trial of fidaxomicin in Clostridium difficile infection (CDI), sponsored by Astellas Pharma. Started Aug 2015; status: completed.
02
Drugs
fidaxomicin
03
Conditions
Clostridium difficile infection (CDI)
Beyond the preview
Go deeper on NCT02437591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02437591.